NCT05259163

Brief Summary

The purpose of this study is to establish if LFR-260 (investigational device) is not inferior in effectiveness to a traditional phoropter (control device) when applied in visual acuity test in subjects undergoing a full routine eye examination. LFR-260 proposes to provide information of the visual capabilities of the patient. The test will be provided and supervised by a qualified eye care provider. The informed consent, screening, randomization (into the order of visual test device used), (visual) device testing (to include precision testing, remote and offsite testing) will all occur at a single visit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

February 28, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

June 7, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 6, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2023

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

September 25, 2024

Completed
Last Updated

September 25, 2024

Status Verified

August 1, 2024

Enrollment Period

7 months

First QC Date

February 9, 2022

Results QC Date

June 25, 2024

Last Update Submit

August 30, 2024

Conditions

Keywords

Ocular

Outcome Measures

Primary Outcomes (2)

  • Effectiveness of LFR260 on Visual Acuity Test

    Agreement of LFR-260 (investigational device) to traditional phoropter (comparator device) when applied in visual acuity test (eye chart test) in subjects undergoing a full routine eye examination. Agreement will be determined by demonstrating that the LFR-260 is within 0.5D (+/-) in measuring sphere and cylinder results and within 10 degrees for axis results among subjects with low astigmatism and within 5 degrees among subjects with moderate to high astigmatism from the traditional phoropter.

    Day 0

  • Precision of LFR260 in Repeated Testing

    Precision testing will also be conducted to confirm repeatability and reproducibility of the LFR-260.

    Day 0

Secondary Outcomes (2)

  • Patient Satisfaction Survey

    Day 0

  • Provider Satisfaction Survey

    Day 0

Study Arms (2)

Group 1: LFR-260 first, then traditional phoropter

EXPERIMENTAL

The LFR-260 was administered first in this group, followed by the traditional phoropter. The LFR-260 is a portable digital refractor which allows for determination of refractive error as well as for fully remote refractions during eye exams. The traditional phoropter is intended to be used for distance vision testing in any environment.

Device: LFR-260 portable phoropterDevice: Traditional phoropter (SOC)

Group II: Traditional Phoropter first, then LFR-260

ACTIVE COMPARATOR

The traditional phoropter was administered first in this group, followed by the traditional phoropter. The traditional phoropter is intended to be used for distance vision testing in any environment. The LFR-260 is a portable digital refractor which allows for determination of refractive error as well as for fully remote refractions during eye exams.

Device: LFR-260 portable phoropterDevice: Traditional phoropter (SOC)

Interventions

Portable unit to evaluate visual refractive state of the patient

Group 1: LFR-260 first, then traditional phoropterGroup II: Traditional Phoropter first, then LFR-260

Standard unit for evaluating visual refractive state of the patient

Group 1: LFR-260 first, then traditional phoropterGroup II: Traditional Phoropter first, then LFR-260

Eligibility Criteria

Age12 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The participant or legal guardian is willing and able to understand, sign and date the Ethics committee approved study specific Informed Consent Form.
  • The participant is a male or female between the ages of 12 and 65 (inclusive).
  • The participant has no more than mild to moderate far-sightedness, near-sightedness, astigmatism or anisometropia.
  • The participant is free of ocular and systemic abnormalities that might affect visual functions.

You may not qualify if:

  • The participant has diabetes mellitus (Type 1 or 2).
  • The participant has an autoimmune condition.
  • The participant is pregnant (self-reported).
  • The participant has an active corneal or conjunctival infection.
  • The participant has an active corneal, conjunctival, or intraocular inflammation (i.e. - uveitis).
  • The participant has diabetic retinopathy.
  • The participant has glaucoma or ocular hypertension.
  • The participant has macular degeneration.
  • The participant has had a previous ocular surgery.
  • The participant has ocular and systemic diseases or abnormalities that might affect visual functions.
  • The participant has a history of amblyopia, strabismus, or any other binocular vision abnormality.
  • The participant has a history of AMD (age macular degeneration).
  • The participant is a prisoner, a transient or has been treated for alcohol and/or drug abuse in an inpatient substance abuse program within 6 months prior to proposed study enrolment.
  • The participant will not be able to complete questionnaires.
  • The participant is currently in an investigational study for a similar purpose.
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

MCPHS

Worcester, Massachusetts, 01608, United States

Location

Gold Coast Optometric Vision

Oyster Bay, New York, 11771, United States

Location

MeSH Terms

Conditions

AstigmatismAnisometropia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Raul Mihali
Organization
Evolution Optiks

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
CROSSOVER
Model Details: The investigational product was compared to the traditional phoropter. Subjects were randomized to the order of testing.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2022

First Posted

February 28, 2022

Study Start

June 7, 2022

Primary Completion

January 6, 2023

Study Completion

January 6, 2023

Last Updated

September 25, 2024

Results First Posted

September 25, 2024

Record last verified: 2024-08

Locations